Frontlight ResearchEarly access
Trial site
Wilmot Cancer Institute, University of Rochester
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Myeloproliferative neoplasms2 trials
- Chronic myeloid leukaemia1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 12 trials
- Early phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Kura Oncology, Inc.1 trial
- Omar Aljitawi1 trial
- Protagonist Therapeutics, Inc.1 trial
- Syntrix Biosystems, Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Recruiting
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
Active, not recruiting
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Chronic myeloid leukaemia1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
Site data: ClinicalTrials.govUpdated 19 Nov 2026